Serious drug-induced liver disease secondary to ezetimibe

doi:10.3748/wjg.14.5098

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2254)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

309

HTML

1945

Sum=2254

Aug 28, 2008 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Aug 28, 2008; 14(32): 5098-5099
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5098

Serious drug-induced liver disease secondary to ezetimibe

José Castellote, Javier Ariza, Rosa Rota, Anna Girbau, Xavier Xiol

José Castellote, Javier Ariza, Rosa Rota, Anna Girbau, Xavier Xiol, Hepatology and Liver Transplant Unit, Idibell, Hospital Universitario de Bellvitge, Barcelona 08907, Spain

Author contributions: Castellote J and Xiol X substantially contributed to the design of the study; Ariza J, Rota R and Girbau A helped write the manuscript and made intellectual corrections.

Correspondence to: Dr. José Castellote, PhD, Hepatology and Liver Transplant Unit, Idibell, Hospital Universitario de Bellvitge, C/Feixa Llarga s/n, L’Hospitalet de Llobregat, Barcelona 08907, Spain. jcastellote@csub.scs.es

Telephone: +34-93-2607516 Fax: +34-93-2607883

Received: May 15, 2008
Revised: June 23, 2008
Accepted: June 30, 2008
Published online: August 28, 2008

Core Tip